Normal view

Received — 9 October 2025 ⏭ Most Recent Articles: Clinical Epigenetics

Most Recent Articles: Clinical Epigenetics
FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening Wenfeng Liao · Lianzi Yu · Lufang Zhang · Jie Shao · Guanhua Li · Jialei Hua · Shuya Zhao · Li Jia · Yawei Han · Aimin Zhang · Xin Yao · Yueguo Li and Dong Dong
Clear cell renal cell carcinoma (ccRCC), with rising incidence globally, shows heterogeneous responses to immune checkpoint blockade (ICB). DNA methylation dysregulation impacts tumor immunity, necessitating p...
8 October 2025 at 08:00

FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening

Most Recent Articles: Clinical Epigenetics

By: Wenfeng Liao · Lianzi Yu · Lufang Zhang · Jie Shao · Guanhua Li · Jialei Hua · Shuya Zhao · Li Jia · Yawei Han · Aimin Zhang · Xin Yao · Yueguo Li and Dong Dong

8 October 2025 at 08:00

Clear cell renal cell carcinoma (ccRCC), with rising incidence globally, shows heterogeneous responses to immune checkpoint blockade (ICB). DNA methylation dysregulation impacts tumor immunity, necessitating p...